This study successfully introduced multiple bis-deoxygalactosyl-carborane building blocks to a GRPR-selective ligand, resulting in conjugates carrying up to 80 boron atoms per molecule, which demonstrated successful internalisation into PC3 prostate cancer cells that express the GRPR. Here, GRPR is linked to prostate cancer.